These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 639200)

  • 1. Long-term tocainide therapy for ventricular arrhythmias.
    Winkle RA; Meffin PJ; Harrison DC
    Circulation; 1978 May; 57(5):1008-16. PubMed ID: 639200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a new oral agent (tocainide) in the acute treatment of refractory ventricular arrhythmias.
    Ryan W; Engler R; LeWinter M; Karliner JS
    Am J Cardiol; 1979 Feb; 43(2):285-91. PubMed ID: 760482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy with conventional antiarrhythmic drugs for ventricular arrhythmias.
    Nestico PF; DePace NL; Morganroth J
    Med Clin North Am; 1984 Sep; 68(5):1295-319. PubMed ID: 6436595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the drug treatment of ventricular arrhythmias.
    Nestico PF; Morganroth J
    Int J Dermatol; 1984 Oct; 23(8):558-64. PubMed ID: 6437997
    [No Abstract]   [Full Text] [Related]  

  • 5. Tocainide for refractory symptomatic ventricular arrhythmias.
    Podrid PJ; Lown B
    Am J Cardiol; 1982 Apr; 49(5):1279-86. PubMed ID: 6801955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
    Nestico PF; Morganroth J
    Cardiol Clin; 1986 May; 4(2):285-303. PubMed ID: 3085932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and safety of oral tocainide and quinidine for benign and potentially lethal ventricular arrhythmias.
    Morganroth J; Oshrain C; Steele PP
    Am J Cardiol; 1985 Oct; 56(10):581-5. PubMed ID: 3931448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tocainide for drug-resistant ventricular arrhythmias: efficacy, side effects, and lidocaine responsiveness for predicting tocainide success.
    Winkle RA; Mason JW; Harrison DC
    Am Heart J; 1980 Dec; 100(6 Pt 2):1031-6. PubMed ID: 6778191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic drug combinations in the treatment of ventricular tachycardia.
    Ross DL; Sze DY; Keefe DL; Swerdlow CD; Echt DS; Griffin JC; Winkle RA; Mason JW
    Circulation; 1982 Dec; 66(6):1205-10. PubMed ID: 6814784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tocainide: a new oral antiarrhythmic.
    Hasegawa GR
    Drug Intell Clin Pharm; 1985; 19(7-8):514-7. PubMed ID: 3928308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic drug therapy of ventricular arrhythmias.
    Huang SK; Marcus FI
    Curr Probl Cardiol; 1986 Apr; 11(4):177-240. PubMed ID: 3086035
    [No Abstract]   [Full Text] [Related]  

  • 12. Ventricular arrhythmias: current concepts.
    Nestico PF; Morganroth J
    Compr Ther; 1984 Sep; 10(9):32-6. PubMed ID: 6435947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic agents for chronic ventricular arrhythmias.
    Nestico PF; Morganroth J
    Compr Ther; 1987 Apr; 13(4):26-35. PubMed ID: 3105950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocainide plus quinidine for treatment of ventricular arrhythmias.
    Barbey JT; Thompson KA; Echt DS; Woosley RL; Roden DM
    Am J Cardiol; 1988 Mar; 61(8):570-3. PubMed ID: 3125737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic tocainide therapy for refractory high-grade ventricular arrhythmias.
    Haffajee CI; Sacks GM; Alpert JS; Howe JP; Ockene IS; Paraskos JA; Dalen JE
    Clin Cardiol; 1983 Feb; 6(2):72-8. PubMed ID: 6403267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of tocainide and quinidine for better tolerance and additive effects in patients with coronary artery disease.
    Kim SG; Mercando AD; Fisher JD
    J Am Coll Cardiol; 1987 Jun; 9(6):1369-74. PubMed ID: 3108345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination antiarrhythmic therapy for management of malignant ventricular arrhythmia.
    Patt MV; Grossbard CL; Graboys TB; Lown B
    Am J Cardiol; 1988 Nov; 62(14):18I-21I. PubMed ID: 2461071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of ventricular rhythm disturbances.
    Somberg JC; Miura D; Keefe DL
    Am Heart J; 1986 Jun; 111(6):1162-76. PubMed ID: 2424297
    [No Abstract]   [Full Text] [Related]  

  • 19. A review of the uses and limitations of tocainide--a class IB antiarrhythmic agent.
    Morganroth J; Nestico PF; Horowitz LN
    Am Heart J; 1985 Oct; 110(4):856-63. PubMed ID: 3931446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind randomized comparison of intravenous tocainide versus lidocaine in the treatment of chronic ventricular arrhythmias.
    Mohiuddin SM; Hilleman DE; Mooss AN; Esterbrooks D; Sketch MH; Stengel LA; Butler ML
    Am Heart J; 1987 Aug; 114(2):296-302. PubMed ID: 3111238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.